Navigation Links
High-dose Vorinostat effective at treating relapsed lymphomas
Date:2/4/2013

SEATTLE Patients whose aggressive lymphomas have relapsed or failed to respond to the current front-line chemotherapy regimen now have an effective second line of attack against their disease. Reporting the results of a first-of-its-kind phase 1 clinical trial to test the effectiveness of a new class of drugs to augment standard chemotherapy, a team led by Fred Hutchinson Cancer Research Center scientists found that giving patients high doses of Vorinostat (suberoylanilide hydroxamic acid) in combination with another round of commonly used second-line drugs resulted in a 70 percent response rate, including several patients whose lymphoma cells disappeared entirely.

According to Ajay Gopal, M.D., associate member of the Fred Hutch Clinical Research Division and corresponding author of the paper, published online in the British Journal of Haematology, the study results open the way to potentially solve the dilemma of how to effectively treat patients when modern cancer drugs fail after the first try. And, he said, it sets the stage for using a new class of drugs called histone-deacetylase inhibitors (HDAC), of which Vorinostat is one, to sensitize tumor cells to the cancer-killing effects of chemotherapy.

Patients treated in the trial had several types of lymphoma, however the best responses were seen in those who had Hodgkin and diffuse large B-cell lymphomas, two of the most aggressive types that typically require a stem cell transplant to cure if they are not cured after the first line of treatment. Knocking back the cancer raises the likelihood for a successful transplant.

"The better the response, the better the outcome will be when patients proceed to a stem cell transplant designed to cure them of their disease," said Elizabeth Budde, M.D., Ph.D., a research associate in the Fred Hutch Clinical Research Division and first author of the study.

The researchers noted that while the current front-line chemotherapy drugs are the most eff
'/>"/>

Contact: Dean Forbes
dforbes@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Controlling spine metastases with tumor separation surgery and high-dose stereotactic radiosurgery
2. Announcement: New Website for Effective Environmental Services Just Went Live
3. Family practice offers genetic tests to predict effective psychiatric meds, a CAMH study
4. Constipation Treatments Not Equally Effective: Review
5. Emotional stress reduces effectiveness of prostate cancer therapies in animal model
6. Candida Treatment
7. How “Yeast Infection No More” Can Help People Treat Candida Effectively - Health Reviews
8. Social Scientists call for more effective teaching in Higher Education
9. Chemo Pills Effective, But Patients May Skip Doses
10. Gastric banding an effective long-term solution to obesity
11. As colorectal cancer gets more aggressive, treatment with grape seed extract is even more effective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Myers, FL (PRWEB) July 25, 2014 ... iPhones, iPods, and iPads. The app provides a tailored ... painful and potentially dangerous sunburns and skin damage. In ... the sights, sounds, and capabilities of iTanSmart. , ... describing the app as a ‘better organized’ and ‘great ...
(Date:7/25/2014)... As the category creator and world leader in healthy ... transform and improve individual lives worldwide through its exclusive and ... a successful Austin, Texas based "Xocai Activ Drink" author, is ... July to promote the up and coming mxicorp.com/company/igc Eric Worre ... has been a leader in the Network Marketing Profession for ...
(Date:7/24/2014)... July 25, 2014 iFitDress.com, a renowned ... new range of casual party dresses . According ... party gowns are now offered at discounted prices, up ... this morning until August 04. , Most of ... in the global market. They are popular for special ...
(Date:7/24/2014)... For rats bearing human breast tumors, exposure to dim ... breast cancer drug tamoxifen, according to data published in ... Association for Cancer Research. The negative effects of dim ... rats a melatonin supplement during the night. , "Resistance ... hormone receptor-positive breast cancer," said Steven M. Hill, PhD, ...
(Date:7/24/2014)... Ticket Down is a reliable source for cheap Manchester ... Authority Field on July 26th. For the past four years, the ... the best club teams from around the world to North America ... weeks after its completion, fans – new and old alike – ... in the world compete. Some of these players were already members ...
Breaking Medicine News(10 mins):Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 2Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 3Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 2Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 3Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 4Health News:2014 Casual Party Dresses for Chic Ladies Now at iFitDress.com 2Health News:Exposure to dim light at night may make breast cancers resistant to tamoxifen 2Health News:Manchester United vs. AS Roma Tickets Denver Sports Authority Field at Mile High: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match 2Health News:Manchester United vs. AS Roma Tickets Denver Sports Authority Field at Mile High: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match 3
... , CAMPBELL, Calif., Dec. 1 Last month on a prominent ... Stanford Sleep Disorders Clinic at Stanford University School of Medicine, recommended ... sleep plan for people trying to achieve a better night,s sleep ... for people when they are sleeping," said Dr. Pelayo. "There are ...
... Results of a large-scale clinical trial presented today at ... (RSNA) provide the first strong evidence of the benefit of ... at elevated risk for breast cancer. In addition, the study ... cancer. , "We found that annual screening with ultrasound in ...
... , , CHICAGO, Dec. 2 Targeted ... is a safe, reliable and cost-effective alternative to invasive biopsies ... two studies presented today at the annual meeting of the ... breast ultrasound, we can reduce the number of expensive and ...
... , SEATTLE, Dec. 2 ... today that Ruth Pettengell, M.D. of St. George,s Hospital, University ... trial will present new data on the pixantrone phase III ... Annual Meeting of the American Society of Hematology on Saturday, ...
... standard conservative therapy to a minimally invasive treatment called ... while both treatments help patients in the short run, ... two years later. Results of the study, the first ... meeting of the Radiological Society of North America (RSNA). ...
... ... , ... (Vocus) -- Omnetics Connector Corporation, the world leader in nano-miniature connectors, has announced the ... These are the smallest Mil-Quality circulars available. The threaded metal shell provides a ...
Cached Medicine News:Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 2Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 3Health News:Annual Screening With Breast Ultrasound or MRI Could Benefit Some Women 2Health News:Annual Screening With Breast Ultrasound or MRI Could Benefit Some Women 3Health News:Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty 2Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 2Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 3Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 4Health News:Outpatient disc treatment gives long-term back pain relief 2Health News:Omnetics Announces Newest Addition to Nano Circular Family 2
(Date:7/24/2014)... July 24, 2014  IGI Laboratories, Inc. (NYSE MKT: IG), ... company, announced its financial results for the second quarter ended ... , Total revenues of $6.5 million in the second ... quarter in 2013 , Total revenues of $13.3 million ... of 78% over the same period in 2013 , ...
(Date:7/24/2014)... ANGELES , July 24, 2014 Many new ... they can do to ensure that their practice will be ... purchase the basic supplies they use the most can make ... and many dentists have recently discovered that purchasing discount ... loss. According to successful dentists across ...
(Date:7/24/2014)... N.C. , July 24, 2014 ... has signed an Agreement with Kineticos, a ... consulting company. Kineticos will support LSI Medience in ... sepsis management, to demonstrate utility in clinical trials. ... shown potential utility in diagnosis of sepsis, prognosis ...
Breaking Medicine Technology:IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7Dental Supplies Online is Key to Dental Success...Really! 2LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment 2
... 28, 2011  A 67-year-old man with Alzheimer,s disease is ... outside in near-freezing temperatures thanks to the quick action of ... wearable locator device. Robert Campbell was recovered ... He was located on Victory Boulevard, more than a mile ...
... LOS ANGELES, Feb. 28, 2011 InstaCare Corp. (OTC ... provider of direct to patient diabetes programs, a leading ... chronically ill, and a leading developer of revolutionary cell ... on Thursday, February 24, 2011, the Company filed a ...
Cached Medicine Technology:Staten Island Man Now Safe at Home Thanks to EmSeeQ® Locator Device 2Staten Island Man Now Safe at Home Thanks to EmSeeQ® Locator Device 3InstaCare Files Full Utility Patent for MD@Hand & MD@Work Technologies 2InstaCare Files Full Utility Patent for MD@Hand & MD@Work Technologies 3
Provides 30% more illumination, high light output for true tissue. Wide-angle viewing lens, sealed system for pneumatic otoscopy....
... The Shandon Cryotome FE and FSE are ... Thermo Electron. The microtome is outside of ... cleaning, as well as faster temperature adjustment. ... operation. Complete temperature controls on the main ...
A standard, durable and reliable indirect....
Designed to retain the desired curve during oral intubation....
Medicine Products: